These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33477417)

  • 1. Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment.
    Hassouneh R; Bajaj JS
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials.
    Bajaj JS; Shamsaddini A; Fagan A; Sterling RK; Gavis E; Khoruts A; Fuchs M; Lee H; Sikaroodi M; Gillevet PM
    Hepatol Commun; 2021 Feb; 5(2):258-271. PubMed ID: 33553973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
    Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.
    Bajaj JS; Salzman NH; Acharya C; Sterling RK; White MB; Gavis EA; Fagan A; Hayward M; Holtz ML; Matherly S; Lee H; Osman M; Siddiqui MS; Fuchs M; Puri P; Sikaroodi M; Gillevet PM
    Hepatology; 2019 Nov; 70(5):1690-1703. PubMed ID: 31038755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the gut microbiome in colonization resistance and recurrent
    Seekatz AM; Safdar N; Khanna S
    Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Hepatic Encephalopathy and Clostridioides difficile Infection in Patients With Cirrhosis.
    Tun KM; Hong AS; Batra K; Naga Y; Ohning G
    Cureus; 2022 May; 14(5):e25537. PubMed ID: 35800791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.
    Bajaj JS; Kassam Z; Fagan A; Gavis EA; Liu E; Cox IJ; Kheradman R; Heuman D; Wang J; Gurry T; Williams R; Sikaroodi M; Fuchs M; Alm E; John B; Thacker LR; Riva A; Smith M; Taylor-Robinson SD; Gillevet PM
    Hepatology; 2017 Dec; 66(6):1727-1738. PubMed ID: 28586116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant.
    Bajaj JS; Kakiyama G; Savidge T; Takei H; Kassam ZA; Fagan A; Gavis EA; Pandak WM; Nittono H; Hylemon PB; Boonma P; Haag A; Heuman DM; Fuchs M; John B; Sikaroodi M; Gillevet PM
    Hepatology; 2018 Oct; 68(4):1549-1558. PubMed ID: 29665102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis.
    Bajaj JS; Salzman N; Acharya C; Takei H; Kakiyama G; Fagan A; White MB; Gavis EA; Holtz ML; Hayward M; Nittono H; Hylemon PB; Cox IJ; Williams R; Taylor-Robinson SD; Sterling RK; Matherly SC; Fuchs M; Lee H; Puri P; Stravitz RT; Sanyal AJ; Ajayi L; Le Guennec A; Atkinson RA; Siddiqui MS; Luketic V; Pandak WM; Sikaroodi M; Gillevet PM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31751317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation in hepatic encephalopathy: a systematic review.
    Madsen M; Kimer N; Bendtsen F; Petersen AM
    Scand J Gastroenterol; 2021 May; 56(5):560-569. PubMed ID: 33840331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy.
    Cold F; Baunwall SMD; Dahlerup JF; Petersen AM; Hvas CL; Hansen LH
    Therap Adv Gastroenterol; 2021; 14():17562848211041004. PubMed ID: 34484424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.
    Staley C; Kaiser T; Vaughn BP; Graiziger C; Hamilton MJ; Kabage AJ; Khoruts A; Sadowsky MJ
    mBio; 2019 Jul; 10(4):. PubMed ID: 31337728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.
    Hui W; Li T; Liu W; Zhou C; Gao F
    PLoS One; 2019; 14(1):e0210016. PubMed ID: 30673716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions.
    Shah YR; Ali H; Tiwari A; Guevara-Lazo D; Nombera-Aznaran N; Pinnam BSM; Gangwani MK; Gopakumar H; Sohail AH; Kanumilli S; Calderon-Martinez E; Krishnamoorthy G; Thakral N; Dahiya DS
    World J Hepatol; 2024 Jan; 16(1):17-32. PubMed ID: 38313244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microbiota transplantation for patients on antibiotic treatment with
    Kates AE; Gaulke I; De Wolfe T; Zimbric M; Haight K; Watson L; Suen G; Kim K; Safdar N
    Contemp Clin Trials Commun; 2020 Jun; 18():100576. PubMed ID: 32518854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection.
    Li X; Gao X; Hu H; Xiao Y; Li D; Yu G; Yu D; Zhang T; Wang Y
    Front Microbiol; 2018; 9():2622. PubMed ID: 30450088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
    Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
    J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metagenomic and bile acid metabolomic analysis of fecal microbiota transplantation for recurrent Clostridiodes difficile and/or inflammatory bowel diseases.
    Ramos RJ; Zhu C; Joseph DF; Thaker S; Lacomb JF; Markarian K; Lee HJ; Petrov JC; Monzur F; Buscaglia JM; Chawla A; Small-Harary L; Gathungu G; Morganstern JA; Yang J; Li J; Pamer EG; Robertson CE; Frank DN; Cross JR; Li E
    Med Res Arch; 2022 Oct; 10(10):. PubMed ID: 36618438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.